Takeda Pharmaceutical Company v. Sun Pharma Global Fze
Takeda Pharmaceutical Company v. Sun Pharma Global Fze
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________ TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS U.S.A., INC., TAKEDA PHARMACEUTICALS AMERICA, INC., Plaintiffs-Appellants v. SUN PHARMA GLOBAL FZE, SUN PHARMACEUTICAL INDUSTRIES, LTD., Defendants-Appellees ______________________ 2016-2325 ______________________ Appeal from the United States District Court for the District of New Jersey in No. 3:14-cv-04616-MLC-TJB, Judge Mary L. Cooper. ______________________ JUDGMENT ______________________ ARLENE L. CHOW, Hogan Lovells US LLP, New York, NY, argued for plaintiffs-appellants. Also represented by ERIC J. LOBENFELD, THOMAS SCHMIDT.
MARK DAVID SCHUMAN, Carlson, Caspers, Vanden- burgh, Lindquist & Schuman, P.A., Minneapolis, MN, argued for defendants-appellees. Also represented by SAMUEL T. LOCKNER, JONATHAN CARPENTER, CAROLINE MARSILI. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (PROST, Chief Judge, NEWMAN and DYK, Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
April 10, 2017 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court
Case-law data current through December 31, 2025. Source: CourtListener bulk data.